eIF3d and eIF3e mediate selective translational control of hypoxia that can be inhibited by small molecules.
Cell Rep.
2025 Dec 23;44(12):116643. doi: 10.1016/j.celrep.2025.116643. Epub 2025 Dec 8. PubMed PMID:
41364558; PubMed Central PMCID:
PMC12822916.
Androgen Receptors Promote Oxidative Phosphorylation and Resistance to Palmitate Lipotoxicity in ER-Mutant Breast Cancer.
Endocrinology.
2025 Dec 5;167(1). doi: 10.1210/endocr/bqaf168. PubMed PMID:
41216931; PubMed Central PMCID:
PMC12679916.
PKCδ Regulates DNA Damage and Cell Death through a SIRT6/Nrf2-dependent Antioxidant Response.
Mol Cancer Res.
2025 Sep 4;23(9):779-791. doi: 10.1158/1541-7786.MCR-24-0805. PubMed PMID:
40358612; PubMed Central PMCID:
PMC12354018.
eIF3d and eIF3e mediate selective translational control of hypoxia that can be inhibited by novel small molecules.
bioRxiv.
2025 May 29;. doi: 10.1101/2025.05.29.656739. PubMed PMID:
40501575; PubMed Central PMCID:
PMC12154685.
MIRO2 promotes cancer invasion and metastasis via MYO9B suppression of RhoA activity.
Cell Rep.
2025 Jan 28;44(1):115120. doi: 10.1016/j.celrep.2024.115120. Epub 2024 Dec 24. PubMed PMID:
39723893; PubMed Central PMCID:
PMC11837739.
Emerging roles for Mitochondrial Rho GTPases in tumor biology.
J Biol Chem.
2024 Sep;300(9):107670. doi: 10.1016/j.jbc.2024.107670. Epub 2024 Aug 14. Review. PubMed PMID:
39128718; PubMed Central PMCID:
PMC11402688.
Metabolic reprogramming contributes to radioprotection by protein kinase Cδ.
J Biol Chem.
2023 Oct;299(10):105186. doi: 10.1016/j.jbc.2023.105186. Epub 2023 Aug 21. PubMed PMID:
37611829; PubMed Central PMCID:
PMC10519828.
Parkin ubiquitination of Kindlin-2 enables mitochondria-associated metastasis suppression.
J Biol Chem.
2023 Jun;299(6):104774. doi: 10.1016/j.jbc.2023.104774. Epub 2023 May 2. PubMed PMID:
37142218; PubMed Central PMCID:
PMC10236456.
NPC1 Confers Metabolic Flexibility in Triple Negative Breast Cancer.
Cancers (Basel).
2022 Jul 21;14(14). doi: 10.3390/cancers14143543. PubMed PMID:
35884604; PubMed Central PMCID:
PMC9319388.
MIRO2 Regulates Prostate Cancer Cell Growth via GCN1-Dependent Stress Signaling.
Mol Cancer Res.
2022 Apr 1;20(4):607-621. doi: 10.1158/1541-7786.MCR-21-0374. PubMed PMID:
34992146; PubMed Central PMCID:
PMC8983529.
Mitochondrial Fission and Fusion in Tumor Progression to Metastasis.
Front Cell Dev Biol.
2022;10:849962. doi: 10.3389/fcell.2022.849962. eCollection 2022. Review. PubMed PMID:
35356277; PubMed Central PMCID:
PMC8959575.
Ghost mitochondria drive metastasis through adaptive GCN2/Akt therapeutic vulnerability.
Proc Natl Acad Sci U S A.
2022 Feb 22;119(8). doi: 10.1073/pnas.2115624119. PubMed PMID:
35177476; PubMed Central PMCID:
PMC8872753.
Mitochondrial-derived vesicles compensate for loss of LC3-mediated mitophagy.
Dev Cell.
2021 Jul 26;56(14):2029-2042.e5. doi: 10.1016/j.devcel.2021.06.003. Epub 2021 Jun 24. PubMed PMID:
34171288; PubMed Central PMCID:
PMC8319140.
The mitophagy effector FUNDC1 controls mitochondrial reprogramming and cellular plasticity in cancer cells.
Sci Signal.
2020 Jul 28;13(642). doi: 10.1126/scisignal.aaz8240. PubMed PMID:
32723812; PubMed Central PMCID:
PMC7484983.
Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2.
Cancer Discov.
2020 Sep;10(9):1282-1295. doi: 10.1158/2159-8290.CD-20-0329. Epub 2020 Jun 4. PubMed PMID:
32499221; PubMed Central PMCID:
PMC7483379.
Androgen-induced expression of DRP1 regulates mitochondrial metabolic reprogramming in prostate cancer.
Cancer Lett.
2020 Feb 28;471:72-87. doi: 10.1016/j.canlet.2019.12.017. Epub 2019 Dec 12. PubMed PMID:
31838085.
Multi-Omic Approaches Identify Metabolic and Autophagy Regulators Important in Ovarian Cancer Dissemination.
iScience.
2019 Sep 27;19:474-491. doi: 10.1016/j.isci.2019.07.049. Epub 2019 Aug 6. PubMed PMID:
31437751; PubMed Central PMCID:
PMC6710300.
Altered mitochondrial trafficking as a novel mechanism of cancer metastasis.
Cancer Rep (Hoboken).
2020 Feb;3(1):e1157. doi: 10.1002/cnr2.1157. Epub 2019 Feb 14. Review. PubMed PMID:
32671955; PubMed Central PMCID:
PMC7370516.
Syntaphilin Ubiquitination Regulates Mitochondrial Dynamics and Tumor Cell Movements.
Cancer Res.
2018 Aug 1;78(15):4215-4228. doi: 10.1158/0008-5472.CAN-18-0595. Epub 2018 Jun 13. PubMed PMID:
29898993; PubMed Central PMCID:
PMC6072605.
Mitochondrial Dynamics in Type 2 Diabetes and Cancer.
Front Endocrinol (Lausanne).
2018;9:211. doi: 10.3389/fendo.2018.00211. eCollection 2018. Review. PubMed PMID:
29755415; PubMed Central PMCID:
PMC5934432.
Syntaphilin controls a mitochondrial rheostat for proliferation-motility decisions in cancer.
J Clin Invest.
2017 Oct 2;127(10):3755-3769. doi: 10.1172/JCI93172. Epub 2017 Sep 11. PubMed PMID:
28891816; PubMed Central PMCID:
PMC5617650.
Inhibition of Age-Related Therapy Resistance in Melanoma by Rosiglitazone-Mediated Induction of Klotho.
Clin Cancer Res.
2017 Jun 15;23(12):3181-3190. doi: 10.1158/1078-0432.CCR-17-0201. Epub 2017 Feb 23. PubMed PMID:
28232477; PubMed Central PMCID:
PMC5474161.
A neuronal network of mitochondrial dynamics regulates metastasis.
Nat Commun.
2016 Dec 19;7:13730. doi: 10.1038/ncomms13730. PubMed PMID:
27991488; PubMed Central PMCID:
PMC5187409.
Mitochondrial Akt Regulation of Hypoxic Tumor Reprogramming.
Cancer Cell.
2016 Aug 8;30(2):257-272. doi: 10.1016/j.ccell.2016.07.004. PubMed PMID:
27505672; PubMed Central PMCID:
PMC5131882.
The Mitochondrial Unfoldase-Peptidase Complex ClpXP Controls Bioenergetics Stress and Metastasis.
PLoS Biol.
2016 Jul;14(7):e1002507. doi: 10.1371/journal.pbio.1002507. eCollection 2016 Jul. PubMed PMID:
27389535; PubMed Central PMCID:
PMC4936714.
Cancer cells exploit adaptive mitochondrial dynamics to increase tumor cell invasion.
Cell Cycle.
2015;14(20):3242-7. doi: 10.1080/15384101.2015.1084448. Review. PubMed PMID:
26317663; PubMed Central PMCID:
PMC4825634.
Molecular Pathways: Mitochondrial Reprogramming in Tumor Progression and Therapy.
Clin Cancer Res.
2016 Feb 1;22(3):540-5. doi: 10.1158/1078-0432.CCR-15-0460. Epub 2015 Dec 9. Review. PubMed PMID:
26660517; PubMed Central PMCID:
PMC4738153.
Disabling mitochondrial reprogramming in cancer.
Pharmacol Res.
2015 Dec;102:42-5. doi: 10.1016/j.phrs.2015.08.022. Epub 2015 Sep 10. PubMed PMID:
26365877; PubMed Central PMCID:
PMC4684442.
Survivin promotes oxidative phosphorylation, subcellular mitochondrial repositioning, and tumor cell invasion.
Sci Signal.
2015 Aug 11;8(389):ra80. doi: 10.1126/scisignal.aab1624. PubMed PMID:
26268608; PubMed Central PMCID:
PMC4539531.
PI3K therapy reprograms mitochondrial trafficking to fuel tumor cell invasion.
Proc Natl Acad Sci U S A.
2015 Jul 14;112(28):8638-43. doi: 10.1073/pnas.1500722112. Epub 2015 Jun 29. PubMed PMID:
26124089; PubMed Central PMCID:
PMC4507184.
Adaptive mitochondrial reprogramming and resistance to PI3K therapy.
J Natl Cancer Inst.
2015 Mar;107(3). doi: 10.1093/jnci/dju502. Print 2015 Mar. PubMed PMID:
25650317; PubMed Central PMCID:
PMC4565533.
Regulation of Transcriptional Networks by PKC Isozymes: Identification of c-Rel as a Key Transcription Factor for PKC-Regulated Genes.
PLoS One.
2013;8(6):e67319. doi: 10.1371/journal.pone.0067319. Print 2013. PubMed PMID:
23826267; PubMed Central PMCID:
PMC3694964.
Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells.
J Clin Invest.
2013 Jul;123(7):2907-20. doi: 10.1172/JCI67841. Epub 2013 Jun 10. PubMed PMID:
23921130; PubMed Central PMCID:
PMC3998961.
Control of tumor bioenergetics and survival stress signaling by mitochondrial HSP90s.
Cancer Cell.
2012 Sep 11;22(3):331-44. doi: 10.1016/j.ccr.2012.07.015. PubMed PMID:
22975376; PubMed Central PMCID:
PMC3615709.
Non-small cell lung carcinoma cell motility, rac activation and metastatic dissemination are mediated by protein kinase C epsilon.
PLoS One.
2012;7(2):e31714. doi: 10.1371/journal.pone.0031714. Epub 2012 Feb 27. PubMed PMID:
22384062; PubMed Central PMCID:
PMC3288050.
Proteins kinase Cɛ is required for non-small cell lung carcinoma growth and regulates the expression of apoptotic genes.
Oncogene.
2012 May 17;31(20):2593-600. doi: 10.1038/onc.2011.428. Epub 2011 Sep 26. PubMed PMID:
21996750; PubMed Central PMCID:
PMC3432976.
Differential regulation of gene expression by protein kinase C isozymes as determined by genome-wide expression analysis.
J Biol Chem.
2011 Apr 1;286(13):11254-64. doi: 10.1074/jbc.M110.194332. Epub 2011 Jan 20. PubMed PMID:
21252239; PubMed Central PMCID:
PMC3064181.
Rift valley fever virus infection of human cells and insect hosts is promoted by protein kinase C epsilon.
PLoS One.
2010 Nov 24;5(11):e15483. doi: 10.1371/journal.pone.0015483. PubMed PMID:
21124804; PubMed Central PMCID:
PMC2991366.
Regulation of prostate cancer cell survival by protein kinase Cepsilon involves bad phosphorylation and modulation of the TNFalpha/JNK pathway.
J Biol Chem.
2010 Aug 20;285(34):26033-40. doi: 10.1074/jbc.M110.128371. Epub 2010 Jun 21. PubMed PMID:
20566643; PubMed Central PMCID:
PMC2924002.
A novel cross-talk in diacylglycerol signaling: the Rac-GAP beta2-chimaerin is negatively regulated by protein kinase Cdelta-mediated phosphorylation.
J Biol Chem.
2010 May 28;285(22):16931-41. doi: 10.1074/jbc.M109.099036. Epub 2010 Mar 24. PubMed PMID:
20335173; PubMed Central PMCID:
PMC2878072.
Hallmarks for senescence in carcinogenesis: novel signaling players.
Apoptosis.
2009 Apr;14(4):392-408. doi: 10.1007/s10495-009-0316-z. Review. PubMed PMID:
19169823.
Phorbol ester-induced apoptosis and senescence in cancer cell models.
Methods Enzymol.
2008;446:123-39. doi: 10.1016/S0076-6879(08)01607-8. PubMed PMID:
18603119.
S-Phase-specific activation of PKC alpha induces senescence in non-small cell lung cancer cells.
J Biol Chem.
2008 Feb 29;283(9):5466-76. doi: 10.1074/jbc.M707576200. Epub 2007 Dec 26. PubMed PMID:
18162471.
Benzo[a]pyrene-7,8-dihydrodiol promotes checkpoint activation and G2/M arrest in human bronchoalveolar carcinoma H358 cells.
Mol Pharmacol.
2007 Mar;71(3):744-50. doi: 10.1124/mol.106.032078. Epub 2006 Nov 17. PubMed PMID:
17114299.
What would you like to do?